Abstract Objective To investigate the clinical indicators for early identification of refractory Mycoplasma pneumoniae pneumonia (RMPP) in children. Methods The clinical data of 142 children with Mycoplasma pneumoniae pneumonia (MPP) between January 2014 and June 2015 were retrospectively studied. Among the 142 children, there were 32 cases of RMPP and 110 cases of non-refractory MPP. The clinical data were compared between the RMPP and non-refractory MPP groups. Results The percentage of school-age children in the RMPP group was higher than in the non-refractory MPP group (PPPPPP>40 mg/L and ESR>30 mm/h+LDH>300 IU/L than the non-refractory MPP group (PConclusions RMPP is common in school-age children. Consolidation of lung on chest X-Ray, pleural effusion and increased levels of CRP and ESR+LDH may be helpful to early identification of RMPP in children.
Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumonia pneumonia in children[J]. Pediatr Pulmonol, 2006, 41(3): 263-268.
[2]
Nguipdop DP. Contribution to understanding the dynamics of Mycoplasma pneumoniae infections in England and Wales[D]. London: London School of Hygiene and Tropical Medicine, University of London, 2009.
[3]
Chalker VJ, Stocki T, Mentasti M, et al. Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(7): 915-921.
[4]
Chalker VJ, Stocki T, Litt D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012[J]. Euro Surveill, 2012, 17(6): Pii: 20081.
[5]
Eibach D, Casalegno JS, Escuret V, et al. Increased detection of Mycoplasma pneumoniae infection in children, Lyon, France, 2010 to 2011[J]. Euro Surveill, 2012, 17(8): Pii: 20094.
Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J]. J Infect, 2008, 57(3): 223-228.
[9]
You SY, Jwa HJ, Yang EA, et al. Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children[J]. Allergy Asthma Immunol Res, 2014, 6(1): 22-26.
[10]
Saraya T, Kurai D, Nakagaki K, et al. Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications[J]. Front Microbiol, 2014, 5: 410.
[11]
Lu A, Wang L, Zhang X, et al. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid[J]. Pediatr Pulmonol, 2011, 46(11): 1093-1097.
[12]
Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children[J]. Korean J Pediatr, 2012, 55(2): 42-47.
Oishi T, Narita M, Matsui K, et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia[J]. J Infect Chemother, 2011, 17(6): 803-806.
[15]
JE Shin, Cheon BR, Shim JW, et al. Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma[J]. Korean J Pediatr, 2014, 57(6): 271277.
[16]
Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children[J]. Clin Infect Dis, 2012, 55(12): 1642-1649.
